Maridea Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 1,392 shares of the healthcare conglomerate’s stock, valued at approximately $704,000.
Other large investors have also modified their holdings of the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $40,000. Finally, Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the stock. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $629.32.
Insider Activity at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.33% of the company’s stock.
UnitedHealth Group Trading Down 0.0 %
Shares of UNH opened at $515.47 on Friday. The firm has a 50 day simple moving average of $508.81 and a 200-day simple moving average of $544.62. The stock has a market cap of $471.51 billion, a price-to-earnings ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.83 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Where Do I Find 52-Week Highs and Lows?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What is a Dividend King?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to trade using analyst ratings
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.